Rockwell Medical, Inc. provided earnings guidance for the year 2025. For the year, the company projects net sales to grow in the mid-to-high single digits in 2025 and beyond.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 USD | -1.56% | +7.69% | 0.00% |
05-30 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
05-14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 57.3M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2025